MANGOCEUTICALS, INC. — Form D/A
MANGOCEUTICALS, INC. of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2022-10-11. The offering totals $2.0M, of which $1.5M was reported sold. Industry: Other.
Offering
- Filed: 2022-10-11
- Form: D/A
- Accession: 0001493152-22-028012
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.5M
- Remaining: $500K
- Minimum investment: $25K
- Investors: 19
- Date of first sale: 2022-08-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-457534
Issuer
- Name: MANGOCEUTICALS, INC.
- CIK: 0001938046
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2021
- Address: 15110 DALLAS PKWY, DALLAS, TX, 75248
- Phone: (833) 626-4679
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jonathan Arango | Director | Dallas, TX |
| Jacob Cohen | Director | Detroit, MI |
| Jonathan Arango | Executive Officer | Dallas, TX |
| Jacob Cohen | Executive Officer | Detroit, MI |
Other filings by this issuer (1)
More